Clinical Trials Logo

Clinical Trial Summary

This is a retrospective chart review to evaluate treatment patterns of botulinum toxin Type A for the treatment of facial lines.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01608659
Study type Observational
Source Allergan
Contact
Status Completed
Phase
Start date April 1, 2011
Completion date June 17, 2011

See also
  Status Clinical Trial Phase
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02261493 - A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Completed NCT01600729 - Reliability of the Facial Wrinkle Scale in Japanese Subjects N/A
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Completed NCT01777620 - A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides Phase 4
Completed NCT00842062 - Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation Phase 1/Phase 2
Completed NCT04609020 - Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial Treatment Phase 4
Completed NCT01299103 - Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles N/A